Brian Cahill
2020
Compensation breakdown
Non-Equity Incentive Plan | $136,050 |
---|---|
Option Awards | $655,111 |
Salary | $334,880 |
Stock Awards | $658,980 |
Other | $29,307 |
Total | $1,814,328 |
Cahill received $659K in stock awards, accounting for 36% of the total pay in 2020.
Cahill also received $136.1K in non-equity incentive plan, $655.1K in option awards, $334.9K in salary and $29.3K in other compensation.
Rankings
In 2020, Brian Cahill's compensation ranked 5,970th out of 13,090 executives tracked by ExecPay. In other words, Cahill earned more than 54.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,970 | 54th |
Manufacturing | 2,460 | 56th |
Chemicals And Allied Products | 981 | 57th |
Drugs | 849 | 57th |
Pharmaceutical Preparations | 631 | 57th |
Pay ratio
Brian Cahill's Pay | $1,814,328 |
---|---|
Median Employee's Pay | $254,007 |
Pay Ratio | 7to 1 |
In 2020, the annual total compensation of Brian Cahill was $1,814,328.
The annual total compensation of the median employee at Eagle Pharmaceuticals was $254,007.
The ratio of Brian Cahill's pay to the pay of median employee was therefore 7 to one.
Cahill's colleagues
We found five more compensation records of executives who worked with Brian Cahill at Eagle Pharmaceuticals in 2020.
2020
Scott Tarriff
Eagle Pharmaceuticals
Chief Executive Officer
2020
Pete Meyers
Eagle Pharmaceuticals
Chief Financial Officer
2020
David Pernock
Eagle Pharmaceuticals
Chief Operating Officer
2020
Adrian Hepner
Eagle Pharmaceuticals
Chief Medical Officer
2020
Judith Ng-Cashin
Eagle Pharmaceuticals